Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: Data from the RealiseAF cross-sectional international registry

Heart

Volumn 98, Issue 3, 2012, Pages 195-201

  Steg, P Gabriel ^a,b,c   Alam, Samir ^d   Chiang, Chern En ^e   Gamra, Habib ^f   Goethals, Marnix ^g   Inoue, Hiroshi ^h   Krapf, Laura ^a,b,c   Lewalter, Thorsten ⁱ   Merioua, Ihsen ^j   Murin, Jan ^k   Naditch BrÛlé, Lisa ^j   Ponikowski, Piotr ^l   Rosenqvist, Mårten ^m   Silva Cardoso, José ⁿ   Zharinov, Oleg ^o   Brette, Sandrine ^p   Neill, James O ^q  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c BICHAT HOSPITAL   (France)

^d AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

^g H Hartziekenhuis Roeselare Menen ^*  (Belgium)

^h UNIVERSITY OF TOYAMA   (Japan)

ⁱ UNIVERSITY OF BONN   (Germany)

^j SANOFI   (France)

^k Physics and Informatics   (Slovakia)

^l WROCLAW MEDICAL UNIVERSITY   (Poland)

^m KAROLINSKA INSTITUTE   (Sweden)

ⁿ University of Porto   (Portugal)

^o SHUPYK NATIONAL MEDICAL ACADEMY OF POSTGRADUATE EDUCATION   (Ukraine)

^p Statistician   (France)

^q ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIAC GLYCOSIDE; DISOPYRAMIDE; DOFETILIDE; DRONEDARONE; FLECAINIDE; PROCAINAMIDE; PROPAFENONE; QUINIDINE; SOTALOL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVERSION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE CONTROL; DISEASE REGISTRY; FEMALE; FUNCTIONAL DISEASE; FUNCTIONAL STATUS; HEART ATRIUM FIBRILLATION; HEART RATE; HOSPITALIZATION; HUMAN; INTERNATIONAL COOPERATION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; SINUS RHYTHM; SYMPTOM; VISUAL ANALOG SCALE; WELLBEING;

AGED; ATRIAL FIBRILLATION; CARDIAC RESYNCHRONIZATION THERAPY; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HOSPITALIZATION; HUMANS; MALE; PREVALENCE; PROGNOSIS; QUALITY OF LIFE; REGISTRIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; WORLD HEALTH;

EID: 84655163332     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2011-300550     Document Type: Article

References (36)

1. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-5. (Pubitemid 32424106)
2. Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000 and implications on the projections for future prevalence. Circulation 2006;114:119-25. (Pubitemid 44420743)
3. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J 2006;27:1979-2030. (Pubitemid 44313588)
4. Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31:2369-429.
5. Carlsson J, Miketic S, Windeler J, et al. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol 2003;41:1690-6. (Pubitemid 36584236)
6. Cooper HA, Bloomfield DA, Bush DE, et al. Relation between achieved heart rate and outcomes in patients with atrial fibrillation (from the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] Study). Am J Cardiol 2004;93:1247-53. (Pubitemid 38607392)
7. Corley SD, Epstein AE, DiMarco JP, et al. Relationships between sinus rhythm, treatment and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 2004;109:1509-13. (Pubitemid 38420179)
8. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation - Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet 2000;356:1789-94.
9. Van Gelder IC, Wyse DG, Chandler ML, et al. Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies. Europace 2006;8:935-42. (Pubitemid 44614202)
10. Talajic M, Khairy P, Levesque S, et al. Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation. J Am Coll Cardiol 2010;55:1796-802.
11. Kirchhof P, Auricchio A, Bax J, et al. Outcome parameters for trials in atrial fibrillation: executive summary. Eur Heart J 2007;28:2803-17.
12. Reynolds MR, Ellis E, Zimetbaum P. Quality of life in atrial fibrillation: measurement tools and impact of interventions. J Cardiovasc Electrophysiol 2008;19:762-8.
13. Aves T, Dorian P. Paroxysmal atrial fibrillation and health-related quality of life: the importance of keeping score. Europace 2010;12:606-7.
14. Guédon-Moreau L, Capucci A, Denjoy I, et al. Impact of the control of symptomatic paroxysmal atrial fibrillation on health-related quality of life. Europace 2010;12:634-42.
15. The EuroQoL Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
16. Brooks R. EuroQol: the current state of play. Health Policy 1996;37:53-72. (Pubitemid 26191458)
17. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001;33:337-43. (Pubitemid 32675374)
18. Kind P, Dolan P, Gudex C, et al. Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ 1998;316:736-41. (Pubitemid 28121072)
19. The EuroQoL Group. EQ-5D: A Standardised Instrument for Use as a Measurement of Health Outcome, 2011. http://www.euroqol.org/ (accessed 1 Mar 2011).
20. Kirchhof P, Auricchio A, Bax J, et al. Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. Europace 2007;9:1006-23. (Pubitemid 351773289)
21. Ntep-Gweth M, Zimmermann M, Meiltz A, et al. Atrial fibrillation in Africa: clinical characteristics, prognosis and adherence to guidelines in Cameroon. Europace 2010;12:482-7.
22. Levy S, Maarek M, Coumel P, et al. Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists. Circulation 1999;99:3028-35. (Pubitemid 29270433)
23. Nabauer M, Gerth A, Limbourg T, et al. The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Europace 2009;11:423-34.
24. Nieuwlaat R, Capucci A, Camm AJ, et al. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 2005;26:2422-34. (Pubitemid 41552972)
25. Camm AJ, Breithardt G, Crijns H, et al. Real life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation in the RECORDAF registry. J Am Coll Cardiol 2011;58:493-501.
26. Le Heuzey JY, Breithardt G, Camm J, et al. The RecordAF study: design, baseline data and profile of patients according to chosen treatment strategy for atrial fibrillation. Am J Cardiol 2010;105:687-93.
27. Roy D, Talajic M, Nattel S, et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 2008;358:2667-77. (Pubitemid 351860859)
28. Meiltz A, Zimmermann M, Urban P, et al. Atrial fibrillation management by practice cardiologists: a prospective survey on the adherence to guidelines in the real world. Europace 2008;10:674-80. (Pubitemid 351775267)
29. Dorian P, Jung W, Newman D, et al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol 2000;36:1303-9.
30. Reynolds MR, Lavelle T, Essebag V, et al. Influence of age, sex and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation: the Fibrillation Registry Assessing Costs, Therapies, Adverse events and Lifestyle (FRACTAL) study. Am Heart J 2006;152:1097-103. (Pubitemid 44854803)
31. Van Gelder IC, Groenveld HF, Crijns HJ, et al. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med 2010;362:1363-73.
32. Dorian P, Guerra PG, Kerr CR, et al. Validation of a new simple scale to measure symptoms in atrial fibrillation: the Canadian Cardiovascular Society Severity in Atrial Fibrillation scale. Circ Arrhythm Electrophysiol 2009;2:218-24.
33. Badia X, Arribas F, Ormaetxe JM, et al. Development of a questionnaire to measure health-related quality of life (HRQoL) in patients with atrial fibrillation (AF-QoL). Health Qual Life Outcomes 2007;5:37.
34. Arribas F, Ormaetxe JM, Peinado R, et al. Validation of the AF-QoL, a disease-specific quality of life questionnaire for patients with atrial fibrillation. Europace 2010;12:364-70.
35. Härdén M, Nyström B, Bengtson A, et al. Responsiveness of AF6, a new, short, validated, atrial fibrillation-specific questionnaire - symptomatic benefit of direct current cardioversion. J Interv Card Electrophysiol 2010;28:185-91.
36. Spertus J, Dorian P, Bubien R, et al. Development and validation of the atrial fibrillation effect on quality of life (AFEQT) questionnaire in patients with atrial fibrillation. Circ Arrhythm Electrophysiol 2011;4:15-25.